Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these https://saadzzmo494494.blogoscience.com/42625091/retatrutide-a-promising-new-treatment-for-obesity